Pancreatic secretion Short answer thpe
| Inactive (Zymogen) | Active Form | Action |
|---|---|---|
| Trypsinogen | Trypsin | Splits proteins/peptides into smaller peptides |
| Chymotrypsinogen | Chymotrypsin | Splits proteins/peptides |
| Procarboxypeptidase | Carboxypeptidase | Cleaves terminal amino acids from peptides |
| Stimulus | Source | Target Cell | Effect |
|---|---|---|---|
| Acetylcholine (ACh) | Vagus nerve / enteric nervous system | Acinar cells | Enzyme secretion |
| Cholecystokinin (CCK) | I cells of duodenum/jejunum | Acinar cells | Enzyme secretion |
| Secretin | S cells of duodenum/jejunum | Ductal cells | HCO3- and water secretion |

| Phase | Mediator | Secretion Type | Contribution |
|---|---|---|---|
| Cephalic | Vagus nerve (sight, smell, taste) | Mainly enzymatic | ~20% of total enzymes |
| Gastric | Vagus nerve (gastric distension) | Mainly enzymatic | ~5-10% of total enzymes |
| Intestinal | CCK + Secretin + ACh | Both enzymatic and aqueous | ~70-80% of total secretion |
In flow charts
PANCREAS (Exocrine)
│
├─────────────────────────────────────────┐
│ │
ACINAR CELLS CENTROACINAR + DUCTAL CELLS
│ │
ENZYMATIC COMPONENT AQUEOUS COMPONENT
(Digestive enzymes) (HCO₃⁻ + Na⁺ + H₂O)
│ │
└──────────────┬──────────────────────────┘
│
PANCREATIC DUCT
│
COMMON BILE DUCT
│
PAPILLA OF VATER
│
DUODENUM (via Sphincter of Oddi)
ACINAR CELLS secrete INACTIVE ZYMOGENS
│
┌───────────┼────────────────┐
│ │ │
Trypsinogen Chymotrypsinogen Procarboxypeptidase
│
▼
Reaches DUODENUM
│
├──── Enterokinase (from intestinal mucosa) ──► TRYPSIN
│
└──── Autocatalysis (Trypsin activates itself)
│
TRYPSIN activates
│
┌───────────┴───────────────┐
│ │
Chymotrypsinogen Procarboxypeptidase
│ │
Chymotrypsin Carboxypeptidase
│ │
(splits proteins (releases free
into peptides) amino acids)
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
TRYPSIN INHIBITOR (secreted by acinar cells)
→ Inactivates any accidental trypsin inside the pancreas
→ Failure → ACUTE PANCREATITIS
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
CARBOHYDRATES PROTEINS FATS
│ │ │
Pancreatic Amylase Trypsin Pancreatic Lipase
│ Chymotrypsin Cholesterol Esterase
▼ Carboxypeptidase Phospholipase
Disaccharides + │ │
Trisaccharides ▼ ▼
Peptides + Fatty Acids +
Amino acids Monoglycerides +
Cholesterol
FOOD IN DUODENUM
│
┌────┴────────────────────────────────┐
│ │
Amino acids / Peptides / Acidic Chyme (pH < 4.5)
Fatty acids │
│ │
▼ ▼
I cells (duodenum/jejunum) S cells (duodenum/jejunum)
│ │
CCK released SECRETIN released
into blood into blood
│ │
▼ ▼
ACINAR CELLS DUCTAL CELLS
(CCK-A receptors) (Secretin receptors)
│ │
IP₃ / Ca²⁺ pathway cAMP pathway
│ │
▼ ▼
ENZYME SECRETION HCO₃⁻ + H₂O SECRETION
(Proteases, Lipase, Amylase) (Neutralizes gastric acid)
↑ POTENTIATED BY ↑
Acetylcholine (ACh)
(Vagus nerve)
Acts on BOTH acinar & ductal cells
MEAL INGESTION
│
▼
CEPHALIC PHASE (~20% of enzyme output)
Trigger: Sight / Smell / Taste / Thought of food
Mediator: Vagus nerve → ACh
Product: Mainly ENZYMES (little fluid)
│
▼
GASTRIC PHASE (~5–10% of enzyme output)
Trigger: Gastric distension
Mediator: Vagal reflex → ACh
Product: Mainly ENZYMES (little fluid)
│
▼
INTESTINAL PHASE (~70–80% of total secretion) ← MOST IMPORTANT
Trigger: Chyme enters duodenum
│
├── H⁺ (acid) → Secretin → DUCTAL CELLS → HCO₃⁻ secretion
│
└── Amino acids / Fatty acids → CCK → ACINAR CELLS → ENZYME secretion
+ ACh (vagovagal reflex) potentiates both
Fat in DISTAL small intestine (ileum)
│
▼
Peptide YY (from ileal cells)
│
▼
INHIBITS pancreatic secretion
│
(also: Somatostatin)
│
(also: Sympathetic NS activity)
→ Signals end of intestinal phase of digestion
→ "ILEAL BRAKE" mechanism
STIMULUS → HORMONE/NERVE → CELL TYPE → SECOND MESSENGER → PRODUCT
H⁺ in duodenum → SECRETIN (S cells) → Ductal cells → cAMP → HCO₃⁻ + H₂O
AA/FA in duodenum → CCK (I cells) → Acinar cells → IP₃/Ca²⁺ → ENZYMES
Sight/smell/distension → ACh (Vagus) → Both cells → IP₃/Ca²⁺/cAMP → ENZYMES + HCO₃⁻
Fat in ileum → Peptide YY → ↓ Secretion (inhibition)
Calcium metabolism physiology
TOTAL BODY CALCIUM (~1000 g)
│
┌──────┴───────────────────────────┐
│ │
BONE (~99%) SOFT TISSUES (~1%)
(Reservoir) Cells + ECF
│ │
├─ Structural (99.6%) ├─ Intracellular (~1%)
│ (Hydroxyapatite) └─ Extracellular fluid (~0.1%)
└─ Exchangeable (0.4-1%) ↓
(CaHPO₄, amorphous salts) Normal ECF = 9.4 mg/dL
← Rapid buffer pool (2.4 mmol/L)
TOTAL PLASMA CALCIUM (9.4 mg/dL)
│
┌─────────┼──────────────────────┐
│ │ │
Protein- Complexed IONIZED Ca²⁺
bound with anions (50%) ← PHYSIOLOGICALLY ACTIVE
(41%) (PO₄, citrate)
(9%)
↑ Alkalosis → ↑ protein binding → ↓ free Ca²⁺ → Tetany
↓ Albumin → ↓ total Ca²⁺ (but ionized Ca²⁺ may be normal)
SUNLIGHT (UV-B)
│
▼
SKIN: 7-Dehydrocholesterol
│
▼
Vitamin D₃ (Cholecalciferol) ← also from diet
│
▼ (25-hydroxylase)
LIVER
│
▼
25-Hydroxycholecalciferol (calcidiol) ← storage form; serum marker of Vit D status
│
▼ (1α-hydroxylase) ← KEY REGULATORY STEP
KIDNEY
│
├── STIMULATED by: ↓Ca²⁺, ↓PO₄, ↑PTH
└── INHIBITED by: ↑Ca²⁺, ↑PO₄, ↑1,25-(OH)₂D₃ (feedback)
│
▼
1,25-Dihydroxycholecalciferol (Calcitriol) ← ACTIVE FORM
│
├── Intestine: ↑Ca²⁺ + PO₄ absorption (via calbindin)
├── Bone: ↑Ca²⁺ + PO₄ mobilization (with PTH)
└── Kidney: ↑Ca²⁺ reabsorption (minor)
When Ca²⁺ is HIGH → 25-OH-D → 24,25-(OH)₂D (inactive form)
↓ Plasma Ca²⁺ (< 9 mg/dL)
│
▼
PARATHYROID GLANDS
(detect via CaSR - Calcium-Sensing Receptor)
│
CaSR (G protein-coupled) senses ↓Ca²⁺
│
▼
↑ PTH SECRETED (84 amino acid peptide)
Second messenger: cAMP
│
┌────┴─────────────────────────────────────────┐
│ │ │
BONE KIDNEY INTESTINE
│ │ │
↑ Bone resorption ↑ Ca²⁺ reabsorption ↑ Ca²⁺ absorption
(Osteoclast (distal tubule) (INDIRECT - via
activation via ↑1,25-(OH)₂D₃)
RANKL/RANK) ↓ PO₄ reabsorption
│ (proximal tubule)
↑ Ca²⁺ + PO₄ ↑1α-hydroxylase
into blood → ↑ Calcitriol
│ │
└──────┬───────────┘
▼
↑ Plasma Ca²⁺
│
NEGATIVE FEEDBACK
│
▼
↓ PTH secretion

PTH ACTS ON BONE
│
┌────┴─────────────────────────────────────────────┐
│ │
RAPID PHASE (minutes-hours) SLOW PHASE (days-weeks)
│ │
Activates existing osteocytes Proliferation of osteoclasts
+ osteoblasts (osteolysis) │
│ RANKL (from osteoblasts) + M-CSF
▼ │
Calcium pumped out of bone fluid ▼
into extracellular fluid Osteoclast-mediated bone
resorption (true resorption)
│
↑↑ Ca²⁺ + PO₄ into blood
↑ Plasma Ca²⁺ (> 9-10 mg/dL)
│
▼
THYROID GLAND (Parafollicular / C cells)
│
▼
↑ CALCITONIN SECRETED (32 amino acid peptide)
│
┌────┴────────────────────┐
│ │
BONE KIDNEY
│ │
↓ Osteoclast activity ↓ Ca²⁺ & PO₄
↓ Bone resorption reabsorption (minor)
↑ Ca²⁺ deposition
│
▼
↓ Plasma Ca²⁺
Note: Calcitonin effect is TRANSIENT and WEAK in adult humans
(PTH overrides with compensatory ↑)
DIETARY INTAKE: ~1000 mg/day
│
▼
INTESTINAL ABSORPTION (~350 mg absorbed, ~150 mg secreted back)
Net absorption = 200 mg/day (regulated by Vit D)
│
▼
EXTRACELLULAR FLUID POOL (~1300 mg)
│
┌────┴───────────────────────┐
│ │
BONE exchange KIDNEY
(500 mg/day in & out) ~10,000 mg filtered/day
(rapid buffer) 98% reabsorbed
│ ↓
│ ~200 mg excreted in urine
│
└── FECAL loss ~800 mg/day (unabsorbed + secreted)
GLOMERULAR FILTRATION: ~59% of plasma Ca²⁺ filtered
(ionized 50% + complexed 9%)
│
▼
PROXIMAL TUBULE (60-70% reabsorbed) ← passive, paracellular
│
▼
LOOP OF HENLE (20% reabsorbed)
│
▼
EARLY DISTAL TUBULE (10% reabsorbed)
│
▼
LATE DISTAL TUBULE / COLLECTING DUCT (variable ~5-10%)
← THIS IS THE REGULATED STEP ←
PTH → ↑ Ca²⁺ reabsorption
↑ Ca²⁺ → ↓ Ca²⁺ reabsorption
│
▼
URINE: ~200 mg/day excreted
↓ Ca²⁺ (hypocalcemia)
│
┌──────┴──────────────────────────────┐
│ │
↑ PTH secretion ↑ Calcitriol (1,25-OH₂D₃)
(parathyroid) (kidney, stimulated by PTH)
│ │
┌────┴──────────────┐ ┌───────┴────────────┐
│ │ │ │
BONE KIDNEY INTESTINE BONE
↑ Resorption ↑ Ca²⁺ reabsorp ↑ Ca²⁺ absorp ↑ Ca²⁺ mob.
↑ Ca²⁺ into ECF ↓ PO₄ reabsorp
│
▼
↑ PLASMA Ca²⁺ ← RESTORED
│
Negative feedback:
CaSR on parathyroid →
↓ PTH → equilibrium restored
↑ Ca²⁺ (hypercalcemia)
│
↑ Calcitonin (C cells of thyroid)
│
↓ Osteoclast activity
↑ Ca²⁺ deposition in bone
│
▼
↓ Plasma Ca²⁺ ← restored
HORMONE │ SOURCE │ Trigger │ Effect on Ca²⁺ │ Effect on PO₄
────────────────────────────────────────────────────────────────────────────────
PTH │ Parathyroid │ ↓ Ca²⁺ │ ↑ (raise) │ ↓ (lower)
Calcitriol │ Kidney (Vit D) │ ↑ PTH / ↓Ca²⁺ │ ↑ (raise) │ ↑ (raise)
Calcitonin │ C cells/Thyroid │ ↑ Ca²⁺ │ ↓ (lower) │ ↓ (lower)
In short answer type
| Form | % | Notes |
|---|---|---|
| Ionized (free) Ca²⁺ | 50% | Active form; regulated |
| Protein-bound (mainly albumin) | 41% | Inactive; affected by albumin levels |
| Complexed (PO₄, citrate) | 9% | Inactive |
Key point: Alkalosis → ↑ protein binding → ↓ free Ca²⁺ → tetany despite normal total Ca²⁺
| Organ | Effect on Ca²⁺ | Effect on PO₄ |
|---|---|---|
| Bone | ↑ resorption (osteoclast activation via RANKL) → ↑ Ca²⁺ release | ↑ PO₄ release |
| Kidney | ↑ reabsorption (distal tubule) | ↓ reabsorption (phosphaturic effect) |
| Kidney | ↑ 1α-hydroxylase → ↑ Calcitriol | - |
| Intestine | ↑ absorption (indirect, via calcitriol) | ↑ absorption |

Important: Calcitonin effect is transient and weak in adult humans. PTH is the dominant regulator. Calcitonin is more significant in children and young animals.
| Process | Amount |
|---|---|
| Dietary intake | ~1000 mg/day |
| Intestinal absorption | ~350 mg absorbed |
| Intestinal secretion | ~150 mg back into gut |
| Net absorption | ~200 mg/day |
| Urinary excretion | ~200 mg/day |
| Fecal loss | ~800 mg/day |
| PTH | Calcitriol (Vit D) | Calcitonin | |
|---|---|---|---|
| Source | Parathyroid gland | Kidney | Thyroid C cells |
| Trigger | ↓ Ca²⁺ | ↑ PTH / ↓ Ca²⁺ | ↑ Ca²⁺ |
| Ca²⁺ effect | ↑ Raise | ↑ Raise | ↓ Lower |
| PO₄ effect | ↓ Lower | ↑ Raise | ↓ Lower |
| Main site | Bone + Kidney | Intestine | Bone |
| Condition | Mechanism | Ca²⁺ | PO₄ | PTH |
|---|---|---|---|---|
| Hypoparathyroidism | ↓ PTH | ↓ | ↑ | ↓ |
| Hyperparathyroidism | ↑ PTH | ↑ | ↓ | ↑ |
| Vitamin D deficiency | ↓ Ca²⁺ absorption | ↓ | ↓ | ↑ (secondary) |
| Renal failure | ↓ 1α-hydroxylase | ↓ | ↑ | ↑ (secondary) |
| Hypocalcemia | ↓ free Ca²⁺ | Tetany, ↑ neuroexcitability | - | - |
| Hypercalcemia | ↑ free Ca²⁺ | CNS depression, ↓ neuroexcitability | - | - |